Push wire for endoluminal medical device
US-2018304042-A1 · Oct 25, 2018 · US
US2018366238A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2018366238-A1 |
| Application number | US-201815996554-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jun 4, 2018 |
| Priority date | Jun 14, 2017 |
| Publication date | Dec 20, 2018 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
One aspect relates to a coil comprising at least two composite wires. The composite wire includes a first part and a second part. The first part is a metallic component. The second part includes an alloy of: a) Cr in the range from about 10 to about 30 wt. %; b) Ni in the range from about 20 to about 50 wt. %; c) Mo in the range from about 2 to about 20 wt. %; d) Co in the range from about 10 to about 50 wt. %. The Al content of the Cr, Ni, Mo and Co alloy is less than about 0.01 wt. % and each wt. % is based on the total weight of the alloy. The first part may at least partially surround the second part when seen in a cross section.
Opening claim text (preview).
What is claimed is: 1 . A composite wire comprising a first part; and a second part; wherein the first part is a metallic component; and wherein the second part includes an alloy comprising the following alloy components: a) Cr in the range from about 10 to about 30 wt. %; b) Ni in the range from about 20 to about 50 wt. %; c) Mo in the range from about 2 to about 20 wt. %; d) Co in the range from about 10 to about 50 wt. %; wherein the Al content of the alloy is less than about 0.01 wt. %; and wherein each wt. % is based on the total weight of the alloy. 2 . The composite wire of claim 1 , wherein the Cr, Ni, Mo and Co components are major constituents of the second part with at least about 95 wt. % of the alloy being Cr, Ni, Mo and Co. 3 . The composite wire of claim 1 , wherein the first part at least partially surrounds the second part when seen in a cross section, and wherein the first part is in one embodiment, biocompatible. 4 . The composite wire of claim 1 , wherein the composite wire further comprises a core part, which is at least partially surrounded by the second part when seen in a cross section. 5 . The composite wire of claim 4 , wherein the core part is a metallic component. 6 . The composite wire of claim 1 , wherein the second part at least partially surrounds the first part when seen in a cross section. 7 . The composite wire of claim 1 , wherein the composite wire further includes a circumference part, which at least partially surrounds the second part when seen in a cross section, and wherein the circumference part is biocompatible. 8 . The composite wire of claim 1 , wherein a diameter of the composite wire is in a range of 10 to 500 μm. 9 . The composite wire of claim 1 , wherein the composite wire further comprises a coating as outermost part at least partially surrounding all other parts. 10 . The composite wire of claim 9 , wherein the coating provides electrical insulation. 11 . The composite wire of claim 9 , wherein the coating comprises at least one of a group of enzymes, antimicrobials, and steroids. 12 . A coil comprising at least two composite wires of claim 1 wound together. 13 . The coil of claim 12 , wherein at least some of the composite wires are electrically insulated from each other. 14 . A cable comprising at least three composite wires according to claim 1 stranded together. 15 . A medical device comprising at least one of the group of a composite wire, a coil and a cable according to claim 1 as a lead. 16 . The medical device of claim 15 , wherein the lead is configured for at least one of a group of: pacing, defibrillating, cardiac resynchronization, and stimulation to nerves or neural tissue in deep brain, spinal cord, vagus nerve or a peripheral nerve. 17 . A manufacturing method for a composite wire, comprising: providing a first part and a second part concentric to each other when seen in a cross section, and joining the first part and the second part together, wherein the first part is a metallic component, and wherein the second part includes an alloy comprising the following alloy components: e) Cr in the range from about 10 to about 30 wt. %; f) Ni in the range from about 20 to about 50 wt. %; g) Mo in the range from about 2 to about 20 wt. %; h) Co in the range from about 10 to about 50 wt. %; wherein the Al content of the alloy is less than about 0.01 wt. %; wherein each wt. % is based on the total weight of the alloy.
Heart stimulators (heart defibrillators A61N1/39) · CPC title
Details · CPC title
of other metals or alloys based thereon · CPC title
Alloys containing less than 50% by weight of each constituent · CPC title
mainly consisting of metals or alloys · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.